Monographie - Propranolol hydrochloride

Propranolol hydrochloride

Σταθερότητα και συμβατότητα των φαρμάκων

χημική δομή

Βιβλιογραφία : Propranolol hydrochloride

	τύπος	δημοσίευση
2477	εφημερίδα	Henry DW, Repta AJ, Smith FM, White SJ. Stability of propranolol hydrochloride suspension compounded from tablets Am J Hosp Pharm 1986 ; 43: 1492-1495.
2504	εφημερίδα	Rooney M, Creurer I. Stability of propranolol hydrochloride suspension and solution Am J Hosp Pharm 1988 ; 45: 530-531.
2513	εφημερίδα	Das Gupta V, Stewart KR. Stability of propranolol hydrochloride suspension and solution compounded from injection or tablets Am J Hosp Pharm 1987 ; 44: 360-361.
3356	εφημερίδα	Geiger C M, Voudrie M A, Sorenson B. Stability of Propranolol Hydrochloride in SyrSpend SF. Int J Pharm Compound 2012 ; 16, 6 : 513-515.
3410	εφημερίδα	Ensom M.H, Kendrick J, Rudolph S, Decarie D. Stability of Propranolol in Extemporaneously Compounded Suspensions Can J Hosp Pharm 2013 ; 66, 2: 118-124.
3996	εφημερίδα	Dijkers E,Nanhekhan V,Thorissen A. Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil. Int J Pharm Compound 2017 ; 21,3 : 240-241.
4177	εφημερίδα	Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Int J Pharm Compound 2018 ;22,6:516-526